Detection of PD-L1 MRNA expression in circulating tumor cells (CTCS) from patients with metastatic NSCLC, HNSCC and melanoma using a novel highly sensitive commercially available CE-IVD KIT.

Authors :: Strati, A.
Zavridou, M.
Smilkou, S.
Tserpeli, V.
Tzanikou, E.
Stergiopoulou, D.
Efthimiadou, E.K.
Tsaroucha, E.
Psyrri, A.
Sfika, A.
Bournakis, E.
Balgouranidou, I.
Boukovinas, I.
Papadimitriou, C.
Kaklamanis, L.
Koukli, I.
Lianidou, E.
Source :: Clinica Chimica Acta. 2024 Supplement 1, Vol. 558, pN.PAG-N.PAG. 1p.
Publication Year :: 2024

Subjects :: *GENE expression
*PROGRAMMED death-ligand 1
*MELANOMA
*NON-small-cell lung carcinoma
*METASTASIS
*BRAF genes

Full Text Access

Tools